Trial Profile
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential-Panel, Multiple Repeat Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Non-Japanese Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Reflux oesophagitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Acronyms TAK438-107
- Sponsors Takeda
- 17 Jun 2013 New trial record
- 17 Jun 2013 New trial record